Literature DB >> 19650202

Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.

Sheng-mei Zhu1, Yong-min Liu, Er-dan An, Qing-lian Chen.   

Abstract

Postherpetic neuralgia (PHN) is a severe sequela of herpes zoster (HZ). Until now, only age and pain severity were considered predisposing factors for the development of PHN. We evaluated 49 patients with acute phase HZ, 10 of whom developed PHN (Group A) and 39 of whom did not develop PHN (Group B). Twenty-five healthy volunteers similar in age and gender distribution to the study group were recruited as controls (Group C). Numbers of serum CD3(+) (pan-T lymphocytes), CD4(+) (helper/inducer), and CD8(+) (suppressor/cytotoxic) lymphocytes were decreased significantly in Groups A and B relative to the control group, but there were no statistical differences between Groups A and B. Interleukin (IL)-1beta, IL-6, tumor necrosis factor (TNF)-alpha, IL-8, and IL-10 were significantly elevated in Groups A and B relative to Group C. IL-6 was significantly higher in Group A than in Group B, and was significantly positively correlated with pain severity scored on a visual analog scale. Therefore, we suggest that the inflammatory response, especially that of IL-6, in the acute phase of HZ may be associated with hyperalgesia and the development of PHN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650202      PMCID: PMC2722705          DOI: 10.1631/jzus.B0920049

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  27 in total

1.  T-lymphocyte subsets in otherwise healthy patients with herpes zoster and relationships to the duration of acute herpetic pain.

Authors:  Kazuo Higa; Banri Noda; Haruhiko Manabe; Sukeyuki Sato; Kenjiro Dan
Journal:  Pain       Date:  1992-10       Impact factor: 6.961

Review 2.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 3.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

Authors:  J Vilcek; T H Lee
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

4.  Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.

Authors:  R Cauda; C E Grossi; R J Whitley; A B Tilden
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

5.  Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster.

Authors:  A Webster; P Grint; M K Brenner; H G Prentice; P D Griffiths
Journal:  J Med Virol       Date:  1989-02       Impact factor: 2.327

6.  The incidence of herpes zoster.

Authors:  J G Donahue; P W Choo; J E Manson; R Platt
Journal:  Arch Intern Med       Date:  1995 Aug 7-21

7.  Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures.

Authors:  Y Zhang; M Cosyns; M J Levin; A R Hayward
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

8.  Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database.

Authors:  Wim Opstelten; Jan W Mauritz; Niek J de Wit; Albert J M van Wijck; Wim A B Stalman; Gerrit A van Essen
Journal:  Fam Pract       Date:  2002-10       Impact factor: 2.267

9.  Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.

Authors:  A Wilson; M Sharp; C M Koropchak; S F Ting; A M Arvin
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

10.  Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.

Authors:  M Zak-Prelich; R C McKenzie; A Sysa-Jedrzejowska; M Norval
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

View more
  15 in total

1.  Plasma Concentrations of Pro-inflammatory Cytokine IL-6 and Antiinflammatory Cytokine IL-10 in Short- and Long-term Opioid Users with Noncancer Pain.

Authors:  Hussam Mizher; Che Suraya Zin; Abul Bashar Helal Uddin; Abdul Hadi Mohamed; Tan H Ling; Munira Izzat
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

2.  Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex.

Authors:  Adel M Nour; Mike Reichelt; Chia-Chi Ku; Min-Yin Ho; Thomas C Heineman; Ann M Arvin
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

3.  Herpes zoster and the risks of osteoporosis and fracture: a nationwide cohort study.

Authors:  Shu-Man Lin; Chih-Yung Wang; Ying-Yu Chen; Jen-Hung Wang; Chung-Chao Liang; Huei-Kai Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-20       Impact factor: 5.103

4.  Local and systemic cytokine expression in patients with postherpetic neuralgia.

Authors:  Nurcan Üçeyler; Michael Valet; Waldemar Kafke; Thomas R Tölle; Claudia Sommer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

5.  Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine.

Authors:  Emmanuel Bäckryd
Journal:  Diagnostics (Basel)       Date:  2015-03-17

Review 6.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

7.  The Development of Translational Biomarkers as a Tool for Improving the Understanding, Diagnosis and Treatment of Chronic Neuropathic Pain.

Authors:  David A Buckley; Elaine M Jennings; Nikita N Burke; Michelle Roche; Veronica McInerney; Jonathan D Wren; David P Finn; Patrick C McHugh
Journal:  Mol Neurobiol       Date:  2017-03-30       Impact factor: 5.590

8.  Post-herpetic neuralgia.

Authors:  Monica Tontodonati; Tamara Ursini; Ennio Polilli; Francesco Vadini; Francesco Di Masi; Damiano Volpone; Giustino Parruti
Journal:  Int J Gen Med       Date:  2012-10-17

9.  Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study.

Authors:  Chieh-Hsin Wu; Chee-Yin Chai; Yi-Ching Tung; Ying-Yi Lu; Yu-Feng Su; Tai-Hsin Tsai; Rong-Dar Tzou; Chih-Lung Lin
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges.

Authors:  Lara El Hayderi; Fany Colson; Bita Dezfoulian; Arjen F Nikkels
Journal:  Psoriasis (Auckl)       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.